FDA clears prasugrel, requires black-box warning

07/12/2009 | Bloomberg

The FDA approved prasugrel, an anti-clotting drug from Daiichi Sankyo and Eli Lilly. The product will be launched under the brand name Effient and carry a black-box warning about an increased risk of potentially fatal bleeding.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO